We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+26.72%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.52B
AUM Growth
+$1.41B
Cap. Flow
+$327M
Cap. Flow %
5.01%
Top 10 Hldgs %
29.27%
Holding
172
New
29
Increased
68
Reduced
18
Closed
14

Top Buys

Rank Stock Value
1
PRAX icon
Praxis Precision Medicines
PRAX
+$137M
2
VITL icon
Vital Farms
VITL
+$64.9M
3
YETI icon
Yeti Holdings
YETI
+$40.8M
4
GTM
ZoomInfo Technologies
GTM
+$36.8M
5
CWEN icon
Clearway Energy Class C
CWEN
+$32.9M

Top Sells

Rank Stock Value
1
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$84.7M
2
IPHI
INPHI CORPORATION
IPHI
+$51M
3
W icon
Wayfair
W
+$46.2M
4
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$37.1M
5
RCKT icon
Rocket Pharmaceuticals
RCKT
+$35.4M

Sector Composition

Rank Sector Weight
1 Healthcare 42.34%
2 Technology 25.33%
3 Industrials 10.16%
4 Consumer Discretionary 6.65%
5 Communication Services 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WCN
26
Waste Connections
WCN
$41.9B
$82.5M 1.26%
804,000
– –
RNG icon
27
RingCentral
RNG
$4.48B
$81.8M 1.25%
215,898
+56,549
+35% +$17.6M
TREX icon
28
Trex
TREX
$4.56B
$73.8M 1.13%
882,000
– –
ODFL icon
29
Old Dominion Freight Line
ODFL
$44.2B
$71M 1.09%
728,000
+14,800
+2% +$1.47M
TPTX
30
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$71M 1.09%
583,000
+200,000
+52% +$21.9M
TRIL
31
DELISTED
Trillium Therapeutics Inc.
TRIL
$70.3M 1.08%
4,781,448
+1,584,440
+50% +$22.8M
APTV icon
32
Aptiv
APTV
$12.3B
$70M 1.07%
537,000
– –
PLRX icon
33
Pliant Therapeutics
PLRX
$65.6M
$64.5M 0.99%
2,838,125
– –
CTAS icon
34
Cintas
CTAS
$82.7B
$63.3M 0.97%
716,000
+184,000
+35% +$16M
MGA icon
35
Magna International
MGA
$19B
$56.9M 0.87%
803,300
+10,200
+1% +$601K
BEP icon
36
Brookfield Renewable
BEP
$9.9B
$53.3M 0.82%
1,236,000
-94,950
-7% -$3.64M
HASI icon
37
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.85B
$52.8M 0.81%
832,200
+5,300
+0.6% +$271K
PANW icon
38
Palo Alto Networks
PANW
$265B
$52.8M 0.81%
891,138
+19,326
+2% +$903K
DHI icon
39
D.R. Horton
DHI
$40.7B
$52.4M 0.8%
759,800
+40,200
+6% +$2.93M
VITL icon
40
Vital Farms
VITL
$536M
$52M 0.8%
+2,053,232
New +$64.9M
BPMC
41
DELISTED
Blueprint Medicines
BPMC
$51.8M 0.79%
462,000
– –
STRO icon
42
Sutro Biopharma
STRO
$411M
$51.5M 0.79%
237,098
+38,500
+19% +$6.37M
ECL icon
43
Ecolab
ECL
$78.6B
$49.8M 0.76%
230,000
– –
ANNX icon
44
Annexon
ANNX
$863M
$49.2M 0.75%
2,004,616
+231,505
+13% +$5.96M
COLL icon
45
Collegium Pharmaceutical
COLL
$1.17B
$48.6M 0.75%
2,427,976
– –
YETI icon
46
Yeti Holdings
YETI
$3.76B
$47.2M 0.72%
+690,000
New +$40.8M
ARGX icon
47
argenx
ARGX
$54.6B
$47.1M 0.72%
160,000
– –
SPT icon
48
Sprout Social
SPT
$509M
$46.1M 0.71%
1,014,920
+34,913
+4% +$1.66M
DDOG icon
49
Datadog
DDOG
$95.6B
$46M 0.71%
467,403
+132,068
+39% +$13.2M
VCYT icon
50
Veracyte
VCYT
$4.77B
$45.5M 0.7%
930,000
– –
1
2
3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, Eventide Asset Management held 172 positions worth $6.52B, up 28% from $5.11B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Eventide Asset Management deployed $327M of net new capital in Q4 2020, opening 29 new positions and adding to 68 existing holdings. Its largest new stake was Praxis Precision Medicines: 234,205 shares worth $184M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 41% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Wayfair, an estimated $46.2M trimmed.

  • Eventide Asset Management's largest Q4 2020 buy was Praxis Precision Medicines: 234,205 shares worth $184M.
  • Eventide Asset Management added most to ZoomInfo Technologies in Q4 2020, an estimated $36.8M increase.
  • Eventide Asset Management's biggest Q4 2020 reduction was Wayfair, cutting an estimated $46.2M.
  • Eventide Asset Management fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $84.7M.
  • Eventide Asset Management's ten largest holdings make up 29% of its $6.52B portfolio in Q4 2020.
  • Eventide Asset Management opened 29 new positions and closed 14 in Q4 2020.
  • Eventide Asset Management's portfolio value rose 28% quarter-over-quarter to $6.52B.

Based on Eventide Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.